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wastewater using a combined UASB-MBR treatment
system
M. J. Moya-Llamas, A. Trapote and D. PratsABSTRACTAn Upflow Anaerobic Sludge Blanket reactor combined with a two-stage membrane bioreactor were
operated for 193 days in order to evaluate the biological removal of carbamazepine (CBZ) from low-
strength municipal wastewater. The system worked in three different organic load stages (0.7±
0.1 kg COD·m3·d1, 0.4± 0.1 kg COD·m3·d1 and 0.1± 0.0 kg COD·m3·d1) to assess the impact
of the influent OLR on operational parameters such as anaerobic and aerobic sludge retention time
(SRT), acidity, volatile fatty acids (VFAs), biomass activity or biogas production. The highest
carbamazepine removals were achieved during the anaerobic stage (UASB reactor), reaching
averages of 48.9%, 48.0% and 38.2% operating at high, medium and low OLR, respectively.
The aerobic treatment (MBR) served as post-treatment, improving the removals, and the global
UASB-MBR system reached averages of 70.0%, 59.6% and 49.8% when the influent was at medium
and low OLR, respectively. The results demonstrate the potential of combined biological systems on
the removal of recalcitrant pharmaceuticals.
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• UASB-MBR was proposed for the removal of the anti-epileptic drug carbamazepine.
• The CBZ removal rates of the UASB-MBR combined system were highly dependent on
the organic loads of the influent.
• UASB-MBR system proved to be particularly suitable for treating municipal waste-
water containing CBZ at OLR above 0.7 kg COD·m3·d1.
• UASB reactor was the main contributor to degradation of the pharmaceutical CBZ.This is an Open Access article distributed under the terms of the Creative
Commons Attribution Licence (CC BY-NC-ND 4.0), which permits copying
and redistribution for non-commercial purposes with no derivatives,
provided the original work is properly cited (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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and microorganisms that have been identified in water only
recently and are under consideration to be regulated (Asano
et al. ). The presence of these ECs in receiving environ-
mental compartments can be a major problem with respect
to the long-term protection of public health and the environ-
ment, as well as an impediment to water reuse. The
persistence of many pharmaceuticals, personal care products
and cleaning agents to conventional wastewater treatment
plants (Luo et al. ), generally based on conventional acti-
vated sludge processes (CAS) has become an urgent but
complex problem for the scientific community.
Carbamazepine (CBZ) (Table 1) is an anti-epileptic and
antidepressant drug with anticonvulsant and analgesicTable 1 | Chemical structure and main physico-chemical properties of CBZ (National
Center for Biotechnology Information 2019)

























1.08·1010properties. It can be used for psychiatric disorders, for
relief of trigeminal neuralgia, or for partial seizures (USP
; Maan & Saadabadi ). Its absorption is slow
and occurs almost completely in the intestinal tract. After
it is absorbed, carbamazepine is heavily metabolized by
the liver (99%) (Zhang et al. ; Dean ) and metab-
olism removes it primarily by the kidneys, being excreted
together with its metabolites and incorporated into waste-
water. Its properties include a high persistence to
biodegradation in the aquatic environment or in biological
processes (Stamatelatou et al. ; König et al. ) and a
low adsorption onto sludge (Ternes et al. ; Kim et al.
). Consequently, carbamazepine and their metabolites
remain in the aqueous phase, being one of the most
widely detected compounds in raw wastewater (Verlicchi
et al. ; Kim et al. ).
The recalcitrant behavior of carbamazepine to conven-
tional biological treatments has been highly reported, being
only removed in percentages below 10% by municipal
wastewater treatment plants (WWTPs) (Ternes ;
Heberer ; Clara et al. ; Suárez et al. ;
Radjenović et al. ; Alvarino et al. ). Therefore, it
is incorporated into water bodies where it has been
detected in the groundwater at concentrations up to
600 ng·L1 (Drewes et al. ; Kaiser et al. ). The
implications of the increasing presence of CBZ and its
metabolites on human health and the environment are
still poorly understood and hardly addressed in the litera-
ture. The European Chemicals Agency (ECHA) (www.
echa.europe.eu; accessed on December 15, 2020) includes
carbamazepine in its databases, mentioning potential
adverse effects such as carcinogenesis, teratogenesis and/
or mutagenesis, bioaccumulation and toxicity. In this
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pollutants is the new Swiss water protection act
(Gewässerschutzgesetz GSchG), implemented in that
country since January 2016, which includes CBZ among
twelve active substances selected to evaluate due different
criteria such as their presence in all large Swiss WWTPs,
not being eliminated by biological treatments and being
detectable with a reliable and ready to use analytical
method. In addition, relevant research such as that con-
ducted by Paltiel et al. () provides concerning results
about the real potential for unwitting human exposure to
CBZ via reclaimed wastewater.
Advanced aerobic treatment technologies as MBRs have
proven to be more effective than conventional activated
sludge (CAS) treatment systems in the removal of certain
micropollutants (Cases et al. ). Nevertheless, in the
case of persistent pharmaceuticals such as carbamazepine,
Hai et al. () addressed only a removal efficiency
around 20% by a MBR flat plate under anoxic and aerobic
conditions operating at low inlet concentration of CBZ
(2–5 μg/L), close to the 28% reached by Gurung et al.
() using the same MBR configuration. Kreuzinger et al.
() informed only a removal efficiency around 11%
with a MBR pilot plant equipped with an ultrafiltration
membrane, and no removal was reported by Clara et al.
() and Radjenović et al. (). Moreover, according
to an exhaustive revision carried out by Simon et al. (),
MBR processes have not been found to be significant in
the removal of CBZ. Regarding other technologies such as
advanced oxidation processes (AOPs), based on the pro-
duction of hydroxyl radicals by different mechanisms,
these have proven to be highly effective in the degradation
of ECs that are refractory to biodegradation. However, its
high operating costs and the generation of numerous inter-
mediates and degradation subproducts, such as epoxy-
carbamazepine or the carcinogenic compound acridine,
constitute a major obstacle to its use (Rivera-Utrilla et al.
). Consequently, new strategies must be developed in
order to decrease the discharged concentration of this per-
sistent and xenobiotic compound.
Anaerobic treatment processes have been well known
for decades in the treatment and removal of biodegrad-
able organic matter from wastewater. They are mainly
based on a high retention of active biomass on the reactor
(Kato ). Although they have traditionally been used
for the treatment and removal of easily biodegradable
organic matter from slaughterhouses, breweries, dairies,
distilleries or paper industries, recent research has demon-
strated their effectiveness in the removal of certainpersistent compounds, such as the analgesic naproxen or
the antibiotics sulfamethoxazole and roxythromycin
from urban wastewater (Carballa et al. ). In this
sense, previous research such as Schwarzenbach et al.
() reported that anaerobic degradation favors biode-
gradation of the persistent ECs through hydrolysis of
amide and urea groups of carbamazepine and atenolol,
which demonstrates that degradation efficiency depends
on the structure and functional group of the compounds
(Tiwari et al. ).
Upflow anaerobic sludge blanket (UASB) reactor
has proven to be a competitive low-cost system for the
direct treatment of municipal wastewater (Rizvi et al.
), being also capable of removing certain compounds,
such as estrogens, bisphenol A or caffeine (Froehner
et al. ). Nevertheless, CBZ has proven to be highly
persistent to anaerobic based treatments. In this sense,
Alvarino et al. () reported its recalcitrant behavior,
achieving low removal rates of CBZ (<15%) treating
municipal wastewater anaerobically and also other
authors such as Carballa et al. () or Stamatelatou
et al. () found no significant removal of CBZ under
anaerobic conditions. According to this, and with the
aim of enhancing its biological removal, two or more
biological technologies combining different redox con-
ditions must be implemented. Conkle et al. ()
investigated different redox conditions (aerobic and
anaerobic conditions) for the degradation of CBZ, con-
cluding that variations in redox conditions play an
important role in the degradation of certain pharmaceu-
ticals such as carbamazepine.
In this context, innovative wastewater treatment sys-
tems combining aerobic and anaerobic biological
processes are a cost-effective and environmentally sustain-
able alternative for the removal of ECs in municipal
wastewaters (Qiu et al. ; Alvarino et al. ; Niwa
et al. ). Their main advantages are low operating and
maintenance costs, low rate of sludge production or the
generation of biogas with a high content of methane suit-
able for the energy recovery of the system (Rosa et al.
). The possible configurations of these systems are
many and varied; however, recent studies present a two
stage UASB-MBR combined system as a particularly prom-
ising configuration for the treatment of municipal
wastewater (Qiu et al. ; Alvarino et al. ; Moya
et al. ; Niwa et al. ). The use of the anaerobic
UASB reactor as a first stage of organic matter degradation
with considerably lower energy consumption than aerobic
systems, together with the complementary treatment of
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in a treated effluent of excellent quality, thus optimizing
the cost-effectiveness ratio.
The organic loading rate (OLR) is a key parameter in
the performance of UASB reactors that indicates their
capacity for methanogenic conversion. Although previous
studies such as that conducted by Lettinga et al. (),
Álvarez et al. () or Buntner et al. () have demon-
strated the feasibility of anaerobic systems treating low
organic loading effluents like domestic, municipal and cer-
tain industrial effluents, the OLR of the influent is usually a
limiting factor in the performance of biological reactors,
particularly anaerobic ones. However, the efficiency of
these combined systems treating low OLR urban effluents
has not yet been addressed. In this sense, the combination
of UASB and MBR systems have generally been applied to
treatment of municipal effluents with organic loads above
1 kg COD·m3·d1, as corroborated by Niwa et al. ()
(1.0–3.3 kg COD·m3·d1), Farajzadehha et al. () (7.2–
10.8 kg COD·m3·d1) or Buntner et al. () (4.85 kg
COD·m3·d1). Regarding the influence of OLR on the
removal of ECs from municipal wastewater, although it
could be expected that an increase in the OLR will encou-
rage the microbial/enzymatic activity of the anaerobic
reactors as well as the co-metabolic transformation of
ECs, no clear correlation has been found between this
operational parameter and ECs removal (Gonzalez-Gil
et al. ).
The aim of this research is to evaluate the effective-
ness of a laboratory-scale UASB-MBR combined pilot
plant in the removal of the persistent pharmaceutical car-
bamazepine from low strength municipal wastewater.
Additionally, the impact of the organic loading rates of
the influent on the removal efficiency of CBZ was ana-
lyzed. Furthermore, the influence of the presence of
CBZ on main operational parameters such as sludge
retention time (SRT), acidity, microbial activity of the
sludge or biogas production was also evaluated. In this
study, carbamazepine has been chosen as an example of
a persistent drug present at trace concentrations in
municipal WWTP effluents.MATERIALS AND METHODS
Experimental set-up
The laboratory-scale system consisted of a UASB reactor fol-
lowed by a membrane bioreactor (MBR) (Figure 1). Therecirculation implemented between both systems allowed
the pilot plant to operate effectively as a combined UASB-
MBR system. The UASB reactor was designed for a usable
volume of 20 L and was equipped with a three-phase bell-
shaped device for the separation and conduction of the
biogas generated in the methanogenic stage as well as to sep-
arate suspended solids in the UASB. Given the slow growth
of anaerobic bacterial clusters (several months), and in
order to initiate the start-up stage with a well-developed bac-
terial consortium, 8 L of granular sludge from a local
brewery located nearby (Valencia, Spain) were used as
inoculum for the start-up stage of the anaerobic reactor.
The quality and suitability of this granular sludge was veri-
fied by physical-chemical (Table 2) and microbiological
characterization. The identification on the microscope con-
firmed the presence of mature granular macroflocs, some of
them polynucleated, as well as the presence of species such
as Zooglea spp., Cymbella spp. and small flagellated proto-
zoa and phytoflagellates.
The MBR was designed in external submerged configur-
ation, by means of a 12 L aerobic tank for biomass growth
followed by an 8 L membrane tank. The MBR was equipped
with an air supply compressor to maintain the dissolved
oxygen (DO) concentration required for the maintenance
of the aerobic biomass. The concentration of suspended
solids in the mixed liquor was maintained as constant in
both tanks by the arrangement of a recirculation peristaltic
pump. The filtration was carried out by a PDVF hollow-
fiber microfiltration membrane (0.4 μm, 0.2 m2) (mod.
Micronet® R, Porous Fibers, S.L).
The main operating parameters were controlled and
recorded continuously by a PLC equipped with a software
specifically developed and implemented by the research
group. This non-commercial software consisted of a
SCADA (supervisory control and data acquisition) designed
using Visual Basic Studio as the web interface, with allowed
access to pilot-plant information.
The experimental system was designed for the treatment
of municipal wastewater. This substrate was reproduced by
means of synthetic wastewater prepared in the laboratory.
Its composition for a COD reference of 1,200 mg/L con-
sisted mainly of peptone (47.60 g), beef extract (32.59 g)
and micronutrients (0.59 g MgSO4· 7 H2O, 1.18 g CaCl2 ·
2 H2O and 2.07 g NaCl) (Sigma Aldrich, Steinheim,
Germany) and was based on DIN 38 412-L24, which has
been used in previous studies (Holler & Trösch ).
According to Carballa et al. (), Farajzadehha et al.
() and Show et al. (), 1.5 and 3 g of sodium carbonate
and bicarbonate respectively were added regularly to the










COD 6,870 246 mg O2/L
COD5 397 93.1 mg O2/L
pH 7.28 7.07 –
Conductivity 2.43 2.80 mS/cm
Redox potential  224 172 mV
Figure 1 | Combined UASB-MBR laboratory-scale plant scheme.
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alkalinity in the anaerobic reactor. In order to evaluate the
impact of different organic loads on the removal efficiency
of CBZ, the pilot plant was operated in three stages within
the range of municipal wastewaters: high (0.7± 0.1 kg
COD·m3·d1), medium (0.4± 0.1 kg COD·m3·d1) and
low (0.1± 0.0 kg COD·m3·d1). Consequently, the
described substrate was diluted to three different concen-
trations: COD¼ 1,200, 600 and 300 mg O2·L1 respectively.The average values of the main operating parameters of
the UASB-MBR pilot plant during the different stages of the
experimental period are included in Table 3.
Concerning the HRT, this is a key operational parameter
of UASB reactors, being directly associated with the upward
velocity and limited by the hydraulic load applied to the reac-
tor. According to Vassalle et al. () and Alvarino et al.
(), HRT is a critical parameter in the removal of certain
compounds, since it directly affects their degradation.
Taking this into account, and in order to allow high contact
time between the sewage and the sludge inside the reactor,
the UASB was operated at high HRT (37 hr).
Regarding the temperature, the optimum temperature
for the anaerobic digestion ranges from 30 C to 35 C
(Liu & Tay ; Rizvi et al. ). Its influence on the per-
formance of the UASB reactors is particularly relevant,
affecting the hydrolysis processes, the rate of substrate use,
the rate of solids sedimentation and gas transfer, and
also determining the predominant species in the reactor
(Pavlostathis & Giraldo-Gómez ; Lettinga et al. ;
Rizvi et al. ). Nevertheless, several studies have





Period of time (d) 0–55 56–87 88–125 125–193
UASB reactor
T (C) 26± 3 29± 1 31± 1 30± 1
HRT (h) 37 37 37 37
SRT (d) >90 >90 >90 >90
pHsynthetic influent 7.7± 0.5 7.7± 0.3 7.5± 0,4 7.7± 0.2




0.50± 0.13 0.47± 0.20 0.47± 0.21 0.22± 0.12
T (C) 23± 2 27± 2 29± 1 26± 2
HRT (h) 30 30 30 30
SRT (d) 90 90 90 90
pHmixed-liquor 6.9± 0.2 7.0± 0.5 7.4± 0.3 7.4± 0.2
pHpermeate 6.8± 0.2 6.9± 0.3 7.8± 0.4 8.1± 0.1
DO (mg O2/L) 6.1± 2.0 4.8± 2.1 6.0± 4.2 6.2± 3.1
K (L·m2·h1) 35.0± 6.0 24.4± 10.2 87.6± 17.7 50.5± 7.9
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at low ambient temperatures (Kato ; Buntner et al.
; Rizvi et al. ). In this research, the UASB reactor
was started up at ambient temperature, with an average
value of 23 C. However, the effects of daily variations on
the performance of the reactor were observed in this stage.
In order to limit the influence of daily and seasonal vari-
ations of temperature and according to previous research
(Farajzadehha et al. ) temperature in the anaerobic reac-
tor was maintained ranging from 29 C to 31 C throughout
the experimental period (Table 3).
According to Show et al. (), in order to ensure rapid
granulation and a stable treatment process, the start-up stage
was completed when COD removal rates of the UASB-MBR
combined system remained stable at about 98% and pseudo
steady-state conditions were achieved. After that previous
stage, CBZ was introduced regularly into the synthetic influ-
ent at an inlet concentration of 10 μg·L1 (Sigma Aldrich,
Steinheim, Germany). This concentration, similar to those
monitored in the influents of the WWTPs, was also sufficient
for the fraction not removed to be above the detection limits
of the analyzer equipment (Tandem GC-MS equipment GC
Agilent 7890 and MS Agilent 5975). In addition, aerobic
sludge toxicity tests were performed by respirometric
methods (OECD , ) and no signs of inhibition ofaerobic sludge activity were detected at the indicated
concentration.Analytical methods
The control of the main physico-chemical parameters of the
combined system was carried out by analyzing samples
taken daily from the inflows and outflows of both biological
reactors. The periodical determination of the volatile fatty
acids (VFAs) present in the fluidized sludge was also carried
out (GC Agilent Technologies, 7890A, Palo Alto, CA, USA).
To ensure the stability of the UASB reactor and avoid its
acidification, the ratio between alkalinity due to VFA and
that due to bicarbonate was maintained at values below
0.3 (Ripley et al. ; Iza ), keeping the bicarbonate
alkalinity at values between 2,500 and 5,000 mg CaCO3·L
1
(Fannin ). The production and composition of biogas
generated during anaerobic digestion was also used as an
indicator of the proper performance of the anaerobic reac-
tor. Samples of the biogas were taken for the subsequent
analysis of its composition by the Geotech Biogas-5000 ana-
lyzer (Geotechnical Instruments Ltd, U.K.).
With the purpose of detecting a possible decline in
aerobic sludge activity due to the presence of CBZ in the
synthetic substrate, weekly respirometric tests were carried
out (respirometer BM-EVO, Surcis S.L.).
The determination of the outlet CBZ concentrations in
the UASB effluent and the MBR permeate were carried
out by means of Solid Phase Extraction (SPE) in an acid
medium (Thermo ScientificTM DionexTM AutoTrace™
280). Previously, the compound was derivatized in situ
according to the methods proposed by Gómez et al. ()
and Hai et al. (). In order to study the linearity and
repeatability of the method, the percentages of recovery,
limits of quantification (LOQ) and detection (LOD) of the
CBZ were determined. For the analysis of the resulting
samples, a tandem GC-MS equipment was used (GC Agilent
7890 and MS Agilent 5975). The MSD ChemStation soft-
ware was used both for the determination of the sequence
and time of appearance of the different compounds ana-
lyzed and for the subsequent analysis of the results. By the
integration of the chromatograms and their representation
on the calibration line of the compound, the concentration
of CBZ in the analyzed samples was determined according
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(%), Ms is the mass retained in the Oasis® HBL cartridge
(ng), recovery indicates the percentage of specific recovery
of CBZ determined experimentally (%) and V is the total
volume that has passed through the adsorbent material.Figure 3 | Evolution of the pH in the inflows and outflows of the individual reactors and
the combined UASB-MBR system (UASB optimal pH range according to
Lorenzo-Acosta & Obaya-Abreu 2005).
Figure 2 | Structure of anaerobic granular sludge of recent formation in UASB stage
(×10).RESULTS AND DISCUSSION
The combined UASB-MBR pilot plant treating synthetic
municipal wastewater was operated for 193 days. The
impact of the three different influent OLR stages on the
main operational parameters of the combined system for
improve CBZ removal rates are reported below.
Operational parameters
• Sludge retention time (SRT)
During the experimental period the combined system
operated at high SRT (>90 days) in both reactors, made
possible by performing periodical purges and maintaining
a low upward velocity (0.1 m/h) inside the UASB reactor
(Lettinga & Hulshoff Pol ; Alphenaar et al.). This
allowed the development and specialization of communities
of slow-growing microorganisms in the MBR and the pres-
ence of macroflocs in the mixed liquor, as well as the
adaptation of the biomass to the CBZ compound, as pre-
viously reported by Judd () and Le-Clech et al. ().
As for the UASB, given the low rate of cell growth of
these systems, the high SRT allowed a good development
and maturation of the anaerobic granules (Ahn ), as cor-
roborated by Figure 2.
• Microbial activity of sludge
Respirometric tests revealed a progressive decrease of
the specific oxygen uptake rate (SOUR) coefficient from
4.55 to 1.02 mg O2 ·g MLVSS
1·h, evidencing a slowing
down of the aerobic sludge degrading activity. Although
further studies related to the response of microbial commu-
nities to CBZ must be carried oud, according to Zhang et al.
(), this decrease could be caused by the high SRT in the
reactor together with the possible progressive accumulation
of CBZ onto sludge due to its moderate potential of adsorp-
tion (log Kow¼ 2.45) as well as the disappearance of certain
groups of bacteria in the presence of CBZ (Kraigher et al.
). As expected, the results obtained in relation to the
endogenous decomposition constant -kd indicate that the
decay of the biomass was greater in the initial stages ofoperation, around 3% of the amount of biomass contained
in the reactor. This lysis could be mainly caused by the iner-
tia of the sludge-inoculum, which came from an industrial
WWTP with high organic loads, and its consequent accom-
modation at low OLR of the synthetic influent.
• Acidity of the medium
In general, most methane-producing bacteria can only
function optimally in a pH range of 6.7–7.4 (Bitton ;
Lorenzo-Acosta & Obaya-Abreu ). Agreeing with
Show et al. (), the average values of pH in the UASB
reactor (Figure 3) were kept within the optimum range for
the anaerobic digestion processes. This corroborates the
good control of the bicarbonate alkalinity of the UASB reac-
tor due to the periodical addition of Na2CO3 and NaHCO3.
The concentration of VFA in the anaerobic medium was
very low and the maximum value (437 mg·L1) was reached
during the start-up stage. Acetic acid was the only one pre-
sent during all stages of the experimental period, with a
maximum concentration above 200 mg·L1 (start-up stage),
followed by propionic acid (140 mg·L1) and 4-methylvale-
ric acid. The concentration of VFA decreased throughout
the experimental phase due to its consumption in the differ-
ent stages of anaerobic digestion, which indicated the
Figure 4 | UASB reactor removal rates at different OLRs.
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modation to the presence of CBZ in the influent. Agreeing
with Alvarino et al. (), no VFA accumulation was
observed throughout the experimental period.
• Biogas
Regarding the biogas generated in the UASB reactor, the
maximum average production was 0.48 m3 biogas·kg
COD1 with an average CH4 content of 73%, higher than
that reported by Carballa et al. () and within the accep-
table range of 250–350 mL of CH4· g COD
1 (Farajzadehha
et al. ). Given the small size of the pilot plant and the use
of low strength synthetic effluents, the results were very suc-
cessful. This maximum rate was achieved when the influent
was in high OLR.
Concerning the presence of H2S, the average H2S con-
centration in the biogas was 2,870 ppm, with a maximum
of 4,100 ppm in the start-up stage. Although these values
are within the range of the typical biogas composition
(Surendra et al. ; Braun ), a H2S desulfurization
treatment could be required to decrease these concen-
trations below 0.15% (v/v) (<1500 ppm) in order to
achieve the minimum requirements for energetic use of
biogas (Braun ). According to Ali et al. (), the H2S
concentration in biogas could be significantly minimized
in the UASB reactor by adding iron chloride to the influent
(1:1 ratio to sulfide concentration).
The high content of methane obtained indicates the
good quality of the biogas produced, being suitable for the
energy recovery of the combined system (Surendra et al.
). Considering that pure biogas has a heating value of
35.8 MJ/m3 (9.94 kWh electricity equivalent) (Metcalf &
Eddy ) at standard temperature and pressure, the calori-
fic value of the biogas generated in the UASB system (73%
of CH4) was around 22.4 MJ/m
3. According to Gil et al.
(), the main energy requirements of the combined
system come from the MBR aeration systems, which rep-
resent almost 50% of the total energy requirements of the
MBR, being 2–4 times higher than the energy demand of
conventional activated sludge process. In this sense, the
energy provided through the biogas generated by the
UASB reactor, as well as that generated during the digestion
of aerobic sludge, becomes a key factor for the sustainability
of the UASB-MBR combined system.
Regarding the influence of the operational strategy, in
accordance with Farajzadehha et al. () a very low recir-
culation radio from MBR to UASB (0.01 L·h1) also
contributed to a high methane production. Consequently,the anaerobic digestion process in the UASB reactor
seemed unaffected by the presence of CBZ in the synthetic
influent, as can be seen from the control of VFA or the excel-
lent production of biogas with a high methane content,
particularly at high OLR.Carbamazepine removal
The different redox conditions of both reactor (UASB reactor
and aerobic bioreactor (MBR) and their combined operation
improved the biological removal of CBZ. Although further
studies are required to determine the fraction of CBZ
adsorbed onto sludge, the low biodegradation constant of
CBZ (<0.1 L·g SS1-d1) and its hydrophilic character (log
kow¼ 2.45) suggests a low adsorption rate of the compound,
which mainly remains in the aqueous phase (Zhang et al.
; Reyes-Contreras et al. ; Alvarino et al. ; Vassalle
et al. ). In this regard, similar studies such as Arias et al.
() or Alvarino et al. () found the interactions between
the positively charged form of the compound with the nega-
tively charged surfaces of the microorganisms (sorption) were
not relevant. In this sense, relevant research such as that con-
ducted by Verlicchi et al. () and Kim et al. () only
reported an adsorption percentage around 5%.
• UASB removal rates
The average removal rates of CBZ in the UASB reactor
(Figure 4) indicated a high anaerobic degradation efficiency
of CBZ, reaching 48.9% and 48.0% in the high and medium
OLR stages respectively. According to Wijekoon et al. (),
the presence of nitrogen in the molecular structure of carba-
mazepine, with two nitrogen atoms, could favor the
anaerobic removal of this moderately hydrophilic compound.
At low organic loads of the influent, the average removal
percentage of CBZ was 38.2% due to the decrease in the
Figure 6 | UASB and global UASB-MBR system removal rates at different OLR stages.
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the influent. The low levels of COD in this stage (below
500 mg/L) were not high enough to maintain good con-
ditions for bacterial growth (Show et al. ) and,
consequently, to maintain degradative activity of biomass.
Although anaerobic removal of CBZ is poorly reported,
the anaerobic degradation rates of CBZ reached in the
UASB individual system for all the OLR stages were
higher than those reported in previous research (Alvarino
et al. ) for UASB reactors but closer to those reported
for other anaerobic technologies such as anaerobic
membrane bioreactors (Wijekoon et al. ).
• UASB-MBR removal rates
The double aerobic and anaerobic biological treatment
together with the filtration in the MBR increased the
removal rates obtained in the UASB (Figure 5).
The CBZ removal average values achieved by the global
UASB-MBR were 70.0% in high OLR and 59.6% and 49.8%
when the influent was in medium and low OLR respectively
(Figure 6).
The fraction of the compound remaining in the effluent
(supernatant) of the UASB was partially removed by aerobic
biological treatment and microfiltration of the membrane in
theMBR. The processes that took place in the anaerobic reac-
tor served as a first and key treatment stage for the removal of
CBZ and, according to Alvarino et al. (), the previous
anaerobic stage enhanced the removal of CBZ, being crucial
to improve the removal efficiency in the MBR.
The progressive decrease of the organic load of the influ-
ent resulted in a lower CBZ removal efficiency of both the
UASB reactor and the UASB-MBR combined system
(Figures 3 and 4), confirming that the UASB-MBR combined
system reaches its highest performance when subjected to
high OLRs.Figure 5 | UASB-MBR combined system removal rates at different OLRs.The results indicate the effectiveness of the combined
system for the treatment of synthetic wastewater with low
OLR. Although OLR could be a limiting factor of the per-
formance of UASB reactor, its combination with the MBR
has proven to be efficient in the treatment of low-strength
wastewater, also being capable of removing a high rate of
certain ECs such as the pharmaceutical CBZ. However,
further studies are required in order to analyze the perform-
ance of the combined system treating real low-strength
municipal wastewater from small WWTPs. In addition, the
study of the ECs removal mechanisms in the UASB-MBR
pilot-plant is proposed. For this purpose, both the liquid
phase and the solid phase (adsorption onto aerobic and
anaerobic sludge) should be analyzed.CONCLUSIONS
The UASB-MBR system proved to be an efficient and cost-
effective technology treating low-strength municipal waste-
water. The double anaerobic and aerobic biological
treatment, together with the membrane filtration, were highly
effective in the removal of the pharmaceutical carbamazepine.
• The CBZ removal rates of the UASB-MBR combined
system were highly dependent on the organic loads of
the influent. The recalcitrant behavior of carbamazepine
was demonstrated, being highly persistent to biological
treatments at low concentrations. Nevertheless, the
UASB-MBR system proved to be particularly suitable
for treating municipal wastewater containing CBZ at
OLRs above 0.7 kg COD·m3·d1.
• The respirometric tests carried out throughout the exper-
imental period showed that high sludge age (SRT)
resulted in a significant decrease in biomass activity.
However, the presence of mature anaerobic granules
and aerobic macroflocs confirmed the development of
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good adaptation to the micropollutant CBZ. In addition,
the stability of the pH in both reactors together with the
moderate rates of VFA in the anaerobic reactor and the
generation of excellent quality biogas rich in methane,
corroborated the good performance of the UASB-MBR
system.
• The anaerobic processes that took place in the UASB
reactor were able to partially remove this micropollutant,
particularly when the influent presented high and
medium organic loads. UASB reactor was the main con-
tributor to degradation of the pharmaceutical CBZ.ACKNOWLEDGEMENTS
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